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Today, proteins are typically overexpressed using solubility-enhancing fusion tags that allow for
afﬁnity chromatographic puriﬁcation and subsequent removal by site-speciﬁc protease cleavage.
In this review, we present an alternative approach to protein production using fusion partners spe-
ciﬁcally designed to accumulate in insoluble inclusion bodies. The strategy is appropriate for the
mass production of short peptides, intrinsically disordered proteins, and proteins that can be efﬁ-
ciently refolded in vitro.
There are many fusion protein systems now available for insoluble expression: TrpLE, ketosteroid
isomerase, PurF, and PagP, for example. The ideal fusion partner is effective at directing a wide vari-
ety of target proteins into inclusion bodies, accumulates in large quantities in a highly pure form,
and is readily solubilized and puriﬁed in commonly used denaturants. Fusion partner removal
under denaturing conditions is biochemically challenging, requiring harsh conditions (e.g., cyano-
gen bromide in 70% formic acid) that can result in unwanted protein modiﬁcations. Recent
advances in metal ion-catalyzed peptide bond cleavage allow for more mild conditions, and some
methods involving nickel or palladium will likely soon appear in more biological applications.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heterologous protein overexpression in Escherichia coli often
leads to a signiﬁcant proportion of the target protein accumulating
in dense insoluble aggregates known as inclusion bodies. For most
applications, it is desirable to minimize this phenomenon in order
to maximize the yield of soluble, well-folded, functional protein.
However, in some cases, the insoluble fraction can be collected
and reconstituted to yield large quantities of biologically active
protein. This approach has been used to produce a number of clin-
ically important hormones and peptides since the late 1970s [1].
Despite its historical and commercial signiﬁcance, the methods
associated with insoluble protein production are less well devel-
oped than the corresponding methods for soluble constructs.
Producing protein from insoluble aggregates is convenient and
effective in the case of peptides that do not fold into a stable do-
main. Moreover, a signiﬁcant proportion of genomes, particularly
more complex eukaryotic ones, encode for long (>50 amino acids)
protein sequences that are unstructured or only become structured
upon target binding [2]. Disordered sequences are highly exposed
and therefore available for protein–protein interactions and post-translational modiﬁcations like proteolytic processing and phos-
phorylation [3], making them very important to protein regulation
and signaling networks. However, the high degree of exposure that
makes these sequences biologically interesting also renders them
vulnerable to proteolysis in the setting of heterologous expression
in E. coli. Hence, targeted expression to inclusion bodies would be a
useful strategy for protecting protein from proteolytic degradation.
The applicability of inclusion body-targeted protein expression
is further extended by the development of efﬁcient in vitro
refolding protocols for over a thousand different protein systems
(REFOLD database available on-line at refold.med.monash.edu.au
[4]). Reconstitution protocols generally involve solubilizing inclu-
sion bodies in a strong denaturant and then removing the denatur-
ant through dialysis, rapid dilution, or chromatographic separation
[5]. Refolding is a separate topic that will not be covered here.
This review will focus on the targeted expression of proteins
into inclusion bodies using fusion partners, solubilization and puri-
ﬁcation under denaturing conditions, and cleavage methods to re-
move the fusion partner under denaturing conditions.
2. Fusion partners for targeting proteins to inclusion bodies
A number of proteins have been proposed as fusion partners for
targeted expression into inclusion bodies. One may ask why a
fusion partner is necessary when inclusion body formation is so
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fusion partner is not needed when a protein overexpresses ro-
bustly into inclusion bodies. However, while many difﬁcult-to-ex-
press proteins appear to partition primarily into the insoluble
fraction, this is not necessarily the fate of the majority of newly ex-
pressed protein. It is useful to think of proteins as existing in equi-
librium between three states: properly folded, partially folded
intermediates, and aggregated (see Fig. 1). All three states are in
dynamic equilibrium and subject to the action of chaperones and
proteases [6], with the partially folded state being the most prone
to proteolytic degradation. Proteins that are the most difﬁcult to
express are those that exist primarily as partially folded (or mis-
folded) intermediates and are rapidly degraded. Expression can
be improved by shifting the equilibrium towards the folded state
by lowering the temperature, reducing the level of expression,
co-expressing chaperones, or introducing solubilizing or stabilizing
mutations. On the other hand, the protein of interest can also be
protected from degradation by targeting it to inclusion bodies
using an insoluble fusion partner.
Just as certain proteins are more effective as solubilizing fusion
partners, the same can be said of insoluble fusion partners. The ideal
insoluble fusion partner accumulates efﬁciently in inclusion bodies
even when fused to very solubilizing constructs. The TANGO algo-
rithm has been used to predict protein sequences that are most
aggregation-prone, with the most important factors being hydro-
phobicity and b-sheet propensity, but other factors, like alternative
structural propensities, electrostatics, and H-bonding play a role as
well [7].
It is difﬁcult to assess which insoluble fusion partners are most
effective at targeting to inclusion bodies, because there are few
head-to-head comparisons. However, we will review the more
commonly used constructs, those that have been demonstrated
to work with multiple target peptides or proteins.
A very early example of a fusion partner that strongly favors
inclusion body formation is the TrpDLE 1413 sequence [8]. The
trp operon contains a leader sequence, TrpL, which encodes a short
14-amino acid peptide sequence, MKAIFVLKGWWRTS, followed by
a stop codon. A large deletion encompassing part of TrpL and the
ﬁrst protein of the operon, TrpE, resulted in an N-terminal 17-ami-
no acid leader sequence, MKAIFVLKGSLDRDPEF, that produced a
fusion polypeptide with the remaining carboxy-terminal fragment
of TrpE. When this sequence is fused to small peptides, including
somatostatin, insulin, and TGF-a [9], expression in E. coli is greatly
enhanced. When the target protein sequence begins with methio-
nine, the TrpDLE peptide can be cleaved off using cyanogen bro-
mide. This strategy has been used to express numerous peptides
as well as even small membrane proteins [10].Newly
expressed
protein
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Properly folded
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Aggregation,
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Fig. 1. Proteins exist in a dynamic equilibrium between soluble properly folded
forms, partially folded intermediates, and insoluble aggregates. Difﬁcult-to-express
proteins accumulate as partially folded intermediates, the form most susceptible to
proteolytic degradation. Usually, some portion of overexpressed protein will appear
in insoluble aggregates, but shifting the equilibrium strongly towards inclusion
body formation (clear arrow), for instance, through the use of a fusion partner, will
protect the protein from proteolysis and enhance protein production.Another commonly used insoluble fusion partner is ketosteroid
isomerase (KSI) [11], a 14 kDa soluble protein that is very hydro-
phobic, with a strong tendency to accumulate in inclusion bodies.
A KSI fusion system for expressing tandem repeats of peptides is
commercially available as a pET31b (Novagen) expression vector.
The KSI protein and target peptide sequences are expressed with
intervening methionine residues, so that cyanogen bromide cleav-
age separates out KSI and the individual peptides. The mixture of
complete and partial cleavage products can then be puriﬁed using
HPLC.
The strategy of targeted expression in inclusion bodies has also
been used in the production of antimicrobial peptides [12], which
would be useful to protect the expression host from the bacterici-
dal effect of the peptides in theory (although it seems that soluble
fusion proteins have worked as well). Besides the KSI system, mul-
tiple antimicrobial peptides have been expressed in fusion con-
structs utilizing a truncated E. coli PurF fragment [13],
Pseudomonas aeruginosa PaP3.30 protein [14], and the histone fold
domain of the human transcription factor TAF12 [15].
Another recently developed fusion partner was engineered from
the N-terminal autoprotease NPRO from classical swine fever virus
(CSFV), termed EDDIE [16]. The native N-terminal autoprotease
cleaves itself from the CSFV polyprotein to generate the N-termi-
nus of the capsid protein. The CSFV polyprotein can be replaced
by a target protein, so that autocleavage by NPRO releases the target
protein with its own native N-terminus. Overexpressed NPRO accu-
mulates mostly in inclusion bodies, but it is also present in the sol-
uble fraction. The degree of soluble vs. insoluble expression in
fusion constructs depended on the nature of the target protein. Fu-
sion protein was harvested from inclusion bodies, solubilized in
guanidine, and then refolded by rapid dilution, leading to autopro-
teolysis and NPRO release. In vitro proteolytic cleavage was limited
by misfolding and precipitation during the refolding process. The
EDDIE protein incorporated a total of 11 point mutations to in-
crease the solubility of the NPRO protein. While these decreased
the proportion of protein targeted to inclusion bodies, the muta-
tions improved the solubilization of inclusion bodies and subse-
quent refolding of the protease and autoproteolytic cleavage step.
This work demonstrates that if the inclusion body-targeting fusion
partner can be refolded into a soluble form, it can then be cleaved
off under non-denaturing conditions using enzymatic methods
rather than chemical cleavage (see below).
We have recently developed a new PagP-based fusion protein
system for inclusion body-targeted expression [17]. PagP is a
Gram-negative bacterial outer membrane protein. All integral out-
er membrane proteins have a b-barrel architecture with a hydro-
phobic exterior facing the membrane bilayer and a hydrophilic
interior cavity. They are targeted to the outer membrane by a
cleavable signal sequence, but when expressed in a construct lack-
ing the signal sequence, they invariably accumulate in cytoplasmic
inclusion bodies [18]. Inclusion body formation is favored because
of the high b-sheet content of the protein and the inability of the
protein to fold outside of the membrane environment. As a fusion
partner, PagP was more effective than KSI at maintaining a tandem
construct of a troponin I fragment in inclusion bodies [17]. We
have found PagP effective in inclusion body-directed expression
of a wide variety of peptides (unpublished results). Another theo-
retical advantage of using a b-barrel membrane protein is that they
are surprisingly not very hydrophobic, making the inclusion bodies
easier to solubilize.
3. Solubilization and puriﬁcation of inclusion bodies
Inclusion bodies can be harvested from lysed cells using moder-
ate-speed centrifugation. After centrifugation, the inclusion bodies
can be washed with mild detergents or low concentrations of
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strong denaturant like guanidine hydrochloride to intact cells so
as to simultaneously lyse cells and dissolve inclusion bodies, it is
preferable to isolate the inclusion bodies separately, since this
can be an important puriﬁcation step in itself. For instance, washed
inclusion bodies of PagP protein were sufﬁciently pure to allow
crystallization for X-ray diffraction studies without any additional
puriﬁcation steps [19].
Solubilization is a key step in purifying proteins from inclusion
bodies. The denaturant or detergent employed for solubilization is
usually also used for subsequent puriﬁcation or cleavage reactions.
Depending on the target protein and fusion partner, not all dena-
turants are effective at solubilizing inclusion bodies. To our knowl-
edge, 70% formic acid is the strongest denaturing solvent,
sometimes even being used to solubilize alpha helical membrane
proteins. The main issue with formic acid is that it can formylate
serine and threonine residues. 70% triﬂuoroacetic acid has been
suggested as an alternative to 70% formic acid, but it is not as
strong a denaturant as formic acid or 6 M guanidine hydrochloride
[20].
Guanidine hydrochloride is a commonly used denaturant and
appears to be the safest in terms of minimizing protein modiﬁca-
tion side reactions. It is also compatible with nickel afﬁnity chro-
matography, more recently termed ‘‘immobilized metal afﬁnity
chromatography’’ (IMAC), since other metal ions like cobalt and
copper can be used as well. IMAC is the most widely used afﬁnity
puriﬁcation method for denatured proteins. The afﬁnity tag for
IMAC is simple and easy to clone into any protein construct: a min-
imum 6-polyhistidine sequence, –His6–. The sequence binds with
high afﬁnity to the metal ion-bound matrix and can be eluted with
increasing concentrations of imidazole, acidic pH, or a chelating
agent like EDTA. Ionic interactions are minimized through the
use of high salt buffer (500 mM NaCl). Many of the impurities re-
tained in nickel afﬁnity chromatography adhere to the protein of
interest through hydrophobic interactions, including other pro-
teins as well as bacterial endotoxin. These can be removed by a
washing step with detergent or organic solvents [21]. Thus, IMAC
is usually more effective under denaturing conditions than under
native conditions, and it is often the only chromatographic step re-
quired to obtain protein of high purity from washed inclusion
bodies. It is worthwhile to note that IMAC is compatible with
Gdn-HCl, urea, and various detergents like perﬂuorooctanoic acid
[22], an anionic detergent that can also be used to solubilize inclu-
sion bodies.
Compared to guanidine, urea has the advantages of low cost and
compatibility with SDS–PAGE (guanidine precipitates with SDS).
However, over time concentrated urea solutions accumulate isocy-
anate ions that can carbamylate protein amino groups. Another
disadvantage of urea is that it is not as strong a denaturant as gua-
nidine. Some very stable proteins can resist denaturation even in
8 M urea.
Recently, a Japanese group found that the ribosomal protein, L2,
adsorbs strongly to silica particles and used it as a 273-amino acid
fusion partner afﬁnity tag called Si-tag [23]. The protein contains
many disordered segments that are highly positively charged,
and silica adsorption was thought to occur through electrostatic
interactions. Adsorption also occurred in 8 M urea, allowing puriﬁ-
cation under denaturing conditions [24]. Elution was effectively
carried out with 2 M MgCl2.
In similar work, the ‘‘Z-tag’’ was engineered from the 58-amino
acid B domain of staphylococcal protein A to contain a large posi-
tively charged patch on its surface [25]. ‘‘Z-tagged’’ proteins can be
puriﬁed using standard cation exchange chromatography in 8 M
urea [26]. Cation exchange chromatography is very effective in
purifying proteins expressed in E. coli because few endogenous
E. coli proteins adsorb to an anionic matrix.It is worthwhile to note that the most commonly used chro-
matographic methods for protein puriﬁcation, gel ﬁltration chro-
matography and ion exchange chromatography, can be
effectively carried out in 8 M urea.
The extremely high afﬁnity (1015 M) of biotin for avidin/strep-
tavidin can also be exploited for afﬁnity puriﬁcation even in 8 M
urea. Biotinylated protein can be produced in E. coli by the addition
of an AviTag sequence, GLNDIFEAQKIEWHE, where the underlined
K residue is biotinylated [27,28]. Biotinylation can be carried out
in vivo in E. coli with BirA biotin ligase co-expression. One group
afﬁnity puriﬁed biotinylated protein using streptavidin beads un-
der denaturing conditions and then ‘‘eluted’’ the target protein
by an on-column TEV protease digestion [29].
4. Non-enzymatic chemical cleavage methods in denaturing
conditions
Although some applications may not require it, fusion partner
removal is often necessary. Most soluble fusion tags are connected
to the target protein by a protease sensitive linker. The advantage
of proteases like thrombin or TEV protease is the high degree of
efﬁciency and speciﬁcity of cleavage. However, this may not be a
viable option when the fusion partner is soluble only in denaturing
conditions. There are a number of non-enzymatic chemical cleav-
age methods that can be performed under denaturing conditions,
but these typically require harsh conditions that can result in un-
wanted protein modiﬁcations (see Table 1). Many of these chemi-
cal methods were developed in the 1960–1970s.
Most chemical cleavage reactions require acidic or basic condi-
tions. Under the harsh acidic conditions used for amino acid anal-
ysis (e.g., 6 M HCl, 110 C), Asn and Gln are quantitatively
converted to Asp and Glu [30]. Trp and Cys are partially destroyed
at a slower rate [31]. However, these reactions are not signiﬁcant
under the milder acidic conditions used in the methods described
below. A study of Asn deamidation found a half-life of about 40 h
in 0.1 N HCl at 60 C, which is on par with deamidation rates at
neutral pH [32]. At increased temperatures and acidic conditions,
Asp-X can form a cyclic succinimide, which may proceed to pep-
tide bond cleavage, more likely to occur when X = Pro (see below)
[33].
Under alkaline conditions, deamidation of Asn is greatly accel-
erated, especially when it is followed by a Gly [32]. The deamida-
tion occurs through a cyclic succinimide intermediate that can
then proceed to peptide bond cleavage or conversion to Asp or
iso-Asp. Cys is converted to dehydroalanine and Arg to ornithine
at 0.1 M NaOH at 55 C [34]. At 80 C and higher concentrations
of NaOH, Ser and Thr are also destroyed.
Some of the chemicals used for peptide bond cleavage can also
promote amino acid oxidation. Cys and Met are most susceptible,
with oxidation occurring spontaneously at room temperature, so
addition of oxidizing agents or increased temperatures can lead
to complete oxidation of these residues. Tyr and Trp, and to a lesser
extent, His, are also prone to oxidation under harsher conditions
[35]. Amino acid oxidation can occur under acidic, neutral, or alka-
line conditions, although Cys oxidation in particular is facilitated
by alkaline pH (Cys pKa is about 8.3) [36].
Perhaps the most commonly used chemical cleavage method is
cyanogen bromide (CNBr) cleavage [37], likely due to the nearly
quantitative reaction that does not require elevated temperatures
(see Table 1). CNBr cleaves the peptide bond C-terminal to the
Met residue, leaving behind a C-terminal homoserine in place of
methionine and a new N-terminus. Near-complete cleavage is pos-
sible, as long as the Met is not followed by Ser or Thr [38,39]. The
cleavage reaction is typically carried out in 70% formic acid or 6 M
Gdn-HCl with 0.1 M HCl. The reaction is quite speciﬁc under acidic
conditions. More alkaline conditions cause increased side reactions
Table 1
Chemical peptide bond cleavage methods. For references and more details, please refer to text.
Sequence
cleaved
Sample conditions used Observed side reactions
–M– –X–
X = not S, T
100 mM CNBr in 0.1 M HCl + 6 M Gdn-HCl or 100 mM CNBr in 70% formic
acid
M to homoserine; S, T formylation
–D– –P– 0.1 M HCl + 6 M Gdn-HCl or 70% formic acid, >40 C –D–X– succinimide formation, cleavage; S, T formylation; C, M
oxidation
–N– –G– 1 M NH2OH + 6 M Gdn-HCl, pH 9, 45 C N deamidation; N hydroxamate formation; C, M oxidation
– –C– 20 mM CNTB in 6 M Gdn-Hcl, pH 9, 1 M glycine or 1 M NH4OH, 37 C C to dehydroalanine; K carbamylation; N deamidation; C, M oxidation
–W– – 10 mM BNPS-skatole, 80% acetic acid C, M, W, Y oxidation, Y halogenation
Table 2
Metal ion-catalyzed peptide bond cleavage methods. For references and more details, please refer to text.
Sequence cleaved Sample conditions used
–M– – 5 mM cis-[Pt(en)(H2O)2]2+, pH 2.5, 40 C
–D/E–K/R– –S/T–H– 2.5 mM Cu2+ or Ni2+, 50 mM Tris–HCl, pH 9, 62 C
– –S/T–X–H–Z–
X = H, K, R
Z = I, K, L, R, W
2 mM Ni2+, 10 mM Tris–HCl, pH 8.5, 37 C
– –Z–H/M–
Z = any amino acid
5 mM Pd2+, pH 7 at 40 C or pH <3 at 20 C for Z = P; pH <3 at 60 C for Z = everything else
–C–H– – 1 mM Pd2+, 100 mM HBF4, HClO4, or CF3COOH, pH 2, 40 C
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cleavage. Methionine oxidation occurs spontaneously in proteins,
but a pre-cleavage reduction step with b-mercaptoethanol or
potassium iodide can increase cleavage efﬁciency with CNBr [17].
Tryptophan oxidation was minimized through the use of fresh
CnBr [41]. Besides the toxicity of cyanogen bromide, the biggest
disadvantage of cyanogen bromide cleavage is that the protein of
interest cannot contain internal methionine residues.
Cysteine residues can also be cyanylated using 2-nitro-5-thio-
cyanatobenzoic acid (NTCB), and the modiﬁed cysteine residue
then undergoes cleavage of its N-terminal peptide bond at pH 9
[42]. Recent re-examination of this reaction found that cleavage
efﬁciency could be improved by using a high concentration of
ammonia or glycine. Major side products of the reaction are carb-
amylated Lys residues as well as dehydroalanine resulting from b-
elimination of thiocyanate from cyanocysteine [43].
The peptide bond of Asp-Pro has been found to be susceptible to
cleavage under acidic conditions and increased temperature [44].
The major issue with this method is the low efﬁciency in some
cases, likely due to sequence-dependent factors that have yet to
be determined. Some groups have reported essentially complete
cleavage for their construct [33]. However, in almost all cases, high
temperatures (>40 C) and long incubation times are needed to
achieve reasonable cleavage rates, increasing the incidence of un-
wanted side reactions: Asp succinimide formation followed by
cleavage at non-Asp-Pro sites and formylation of Ser/Thr if formic
acid is used. It is important to determine the mildest conditions of
acidity and temperature compatible with an acceptable cleavage
yield.
Another method for chemical cleavage is hydroxylamine cleav-
age at an Asn–Gly bond [45]. The reaction can be carried out in
guanidine- or urea-containing buffer and is favored by high con-
centrations of hydroxylamine (>1 M), high pH (>8.5), and high
temperature. Increasingly harsh conditions improve efﬁciency
but also promote competing side reactions. Along with the peptide
bond cleavage, the Asn residue can be converted to a hydroxamic
acid derivative [46]. As mentioned earlier, the alkaline conditions
cause Asn residues to form cyclic succinimide structures that are
subsequently hydrolyzed to Asp and iso-Asp [32]. Bond cleavagecan also occur at Asn-X sites, where X is another amino acid be-
sides Gly, albeit at lower rates [32,45].
There are a number of oxidizing reagents that can cleave at oxi-
dation-susceptible residues. One of the more mild agents is BNPS-
skatole [2-(2-nitrophenyl)-3-methyl-3-bromoindolenine], which
cleaves Trp–X bonds through oxidative halogenation of the indole
ring of Trp using under acidic conditions (80% acetic acid) [47,48].
This is still a fairly harsh agent that leads to complete oxidation of
Cys and Met residues as well.
5. Metal ion-catalyzed cleavage methods
More recently, various metal ions and chelates have been used
to catalyze peptide bond cleavage under more mild conditions (see
Table 2). Although there is a large body of chemical literature in
this area, these methods have yet to ﬁnd widespread biological
application. One potential problem with metal ion-catalyzed pep-
tide cleavage is the tendency of metal ions to catalyze oxidation
of certain amino acids (His, Arg, Lys, Pro, Met, and Cys) [49]. Oxida-
tive cleavage can be encouraged by the addition of hydrogen per-
oxide or ascorbate [50], but these should probably be avoided
due to the potential for collateral damage to the protein of interest.
We will cover examples of metal ion-catalyzed cleavage where
stringent sequence speciﬁcity would be useful for biological appli-
cations. Since these methods are new and relatively untested com-
pared to the much older chemical cleavage techniques, there is far
less data concerning side reactions. However, most of the tech-
niques require increased temperatures, and one would predict that
amino acid oxidation, particularly Cys and Met, would be an
important consideration.
A proposed alternative to CNBr cleavage (at the peptide bond C-
terminal to Met residues) is platinum-catalyzed cleavage using cis-
[Pt(en)(H2O)2]2+ at pH 2.5 and 40 C [51].
The sequence Asp-Lys-Thr-His was found to be susceptible to
copper(II) ion-catalyzed peptide bond cleavage between Lys and
Thr under basic conditions [52]. Further investigation of this
phenomenon showed that the mechanism was hydrolytic rather
than oxidative [53]. The cleavage efﬁciency could be increased
by changing the peptide sequence to Asp-Lys-Ser-His, allowing
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could also be carried out at a slower rate using nickel(II) ions
instead.
The Bal group has done the most comprehensive work to date in
optimizing amino acid sequences for Ni(II)-catalyzed cleavage.
They focused on the sequence Ser/Thr-X-His-Y, where cleavage oc-
curs N-terminal to the Ser/Thr [54]. Combinatorial library screen-
ing of the four hundred possible amino acid combinations for
positions X and Y determined that a positively charged residue is
favored at position X and a hydrophobic or positively charged res-
idue at position Y, and the optimal sequence was Ser-Arg-His-Trp.
This combinatorial approach could be an important means of opti-
mizing sequences for any cleavage method. This sequence was
used as part of a linker (SRHWAP) between a protease inhibitor
protein, SPI2, and a poly-His tag, and near-complete nickel-cata-
lyzed cleavage was demonstrated under mildly alkaline conditions
(pH 8.2), both in solution and bound to a nickel afﬁnity column
[55]. Recent work by our lab has conﬁrmed the general utility of
this sequence as a cleavable linker for fusion protein constructs.
However, one proviso is that metal ion binding sequences can lead
to irreversible aggregation in the setting of inclusion body-targeted
expression (results to be published).
Palladium(II) binds to His, Cys, and Met and has been found to
catalyze cleavages near these residues. One study found that for X–
Z-Met and X–Z-His sequences, the X–Z bond was susceptible to
Pd2+-catalyzed cleavage under acidic (pH <3.0) conditions (Cys-
containing peptides were not examined) [56]. X-Pro-Met and X-
Pro-His sequences were found to be particularly susceptible to
Pd2+-catalyzed cleavage even under neutral pH conditions. The
susceptibility of the Pro peptide bond to acid-catalyzed cleavage
has already been noted. In this regard, it is interesting to note that
the sequence Gly-Asp-Pro-His was found to be particularly suscep-
tible to acid-catalyzed cleavage (pH <6.0) in human MUC2 mucin
[57].
The same group also found that the His-X peptide bond in the
sequence Cys-His-X was susceptible to Pd2+-catalyzed cleavage un-
der acidic conditions (pH 2), so long as the anion of the acid did not
coordinate Pd2+: e.g., HBF4, HClO4, or CF3COOH [58].
The above examples of sequence-speciﬁc metal ion-catalyzed
cleavage show great promise, but further work is needed to fully
delineate not only the optimal sequences for lower temperature
cleavage, but also the full range of susceptible sequences so that
unwanted cleavages can be minimized.
6. Future directions
Targeted expression of proteins to inclusion bodies using an
insoluble fusion partner is an effective means of producing large
amounts of very pure protein. Although the strategy is quite old,
it is only recently being reﬁned through modern recombinant
DNA and combinatorial library screening techniques. The ideal fu-
sion partner for maximizing expression and purity remains to be
determined. As well, the full range of amino acid sequences for
non-oxidative chemical cleavage under acid-, base-, and metal
ion-catalyzed conditions needs to be further clariﬁed. While most
studies have focused solely on the effect of amino acid sequence
for residues immediately adjacent to the cleaved peptide bond
(1 and +1 positions), it is conceivable that longer range local ef-
fects need to be considered as well (from the 4 to +4 positions).
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